1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Filip Djordjevic
Our people

Filip Djordjevic

Research Assistant

Working groups

filip.djordjevic@burnet.edu.au
Filip Djordjevic

Background

Filip joined Burnet Institute in 2019 on the Disease Elimination and Behaviours and Health Risks programs. He will be conducting research on Eliminating Hepatitis C cohort study as well as policy related to take-home naloxone in Australia.

Qualifications

  • 2018: Masters of Public Health, University of Melbourne
  • 2013: BA (Honours), Swinburne
  • 2012: Bachelor of Social Science, Swinburne

Burnet publications

View 12 more
01 Dec 2024

Feasibility and acceptability of multiple methods of recording injecting drug use episode data among people who inject drugs in Melbourne, Australia: a pilot evaluation study protocol

BMJ Open

Rebekka Petrovic, Filip Djordjevic, Ashleigh C. Stewart, Dylan Vella-Horne, Zoe Gleeson, Damian Pavlyshyn, Matthew S. Gill, Nick Scott, Peter Higgs, Paul Dietze

01 Dec 2024

Feasibility and acceptability of multiple methods of recording injecting drug use episode data among people who inject drugs in Melbourne, Australia: a pilot evaluation study protocol

BMJ Open

Rebekka Petrovic, Filip Djordjevic, Ashleigh C. Stewart, Dylan Vella-Horne, Zoe Gleeson, Damian Pavlyshyn, Matthew S. Gill, Nick Scott, Peter Higgs, Paul Dietze

01 Jul 2023

The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia

BMJ Open

Jack Gunn, Daniel O’Keefe, Bridget Draper, Filip Djordjevic, Kathleen E. Ryan, Phoebe Kerr, Imogen Elsum, Judy Gold, Chloe Layton, Kico Chan

Current projects

Methamphetamine and injecting drug use cohort studies: MIXMAX
Open to students

Methamphetamine and injecting drug use cohort studies: MIXMAX

MIXMAX is the largest active cohort study of people who use drugs in Australia. It combines 2 pre-existing studies: SuperMIX and VMAX.

Methamphetamine use in Melbourne and rural Victoria: the VMAX cohort study
Open to students

Methamphetamine use in Melbourne and rural Victoria: the VMAX cohort study

The VMAX cohort study follows 850 people who use methamphetamine recruited from metropolitan Melbourne and 3 regions of rural Victoria.

Injecting drug use in Melbourne: SuperMIX cohort study
Open to students

Injecting drug use in Melbourne: SuperMIX cohort study

The largest and longest-running active cohort study of people who inject drugs in Australia (since 2008).

Past projects

Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

This study provided evidence on whether a supervised drug consumption room (or rooms) is suited to the ACT context.

On this page